FDA Inspection 1133295 — David S. Siegel, M.D.
The FDA completed an inspection of David S. Siegel, M.D. on November 2, 2020 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 2, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Hackensack, NJ (United States)
Additional Details
Clinical Investigator (CI)